Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Codiak Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Codiak Biosciences Inc market cap is $58,900.00.
What is the 52-week high for Codiak Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Codiak Biosciences Inc 52 week high is $3.23 as of October 10, 2025.
What is the 52-week low for Codiak Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Codiak Biosciences Inc 52 week low is $0.0016 as of October 10, 2025.
What is Codiak Biosciences Inc stock price today?
Codiak Biosciences Inc stock price today is $0.0016.
What was Codiak Biosciences Inc stock price yesterday?
Codiak Biosciences Inc stock price yesterday was $0.0085.
What is the PE ratio of Codiak Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Codiak Biosciences Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Codiak Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Codiak Biosciences Inc P/B ratio is 0.0015.
What is the 50-day moving average of Codiak Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Codiak Biosciences Inc 50-day moving average is $0.0103.
